Differentiated thyroid cancer and positron emission computed tomography: when, how and why?
Journal:
Expert review of anticancer therapy
Published Date:
Jul 9, 2025
Abstract
INTRODUCTION: Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) has become an indispensable tool in oncology, offering both metabolic and anatomical insights into tumor behavior. Most differentiated thyroid carcinomas (DTC) are indolent and therefore FDG PET/CT is not routinely incorporated into management. However, in biologically aggressive DTCs, FDG PET/CT plays a crucial role in detecting recurrence and metastases.
Authors
Keywords
No keywords available for this article.